Management of insulin-dependent diabetes mellitus
- PMID: 1280576
- DOI: 10.2165/00003495-199200443-00006
Management of insulin-dependent diabetes mellitus
Abstract
Insulin therapy has been lifesaving for patients with insulin-dependent diabetes mellitus. Unfortunately, longer lifespan has unmasked microvascular, neurological and macrovascular complications that result in profound morbidity and increased mortality. Driven by the conviction that better physiological control of glycaemic levels will prevent and/or ameliorate long term complications, and by the desire to make diabetes care as user-friendly as possible, clinical research efforts have led to the development of new treatment methods with the aim of achieving near normal metabolic control. Such methods include the use of self monitoring, multiple daily insulin injection regimens, external and implantable insulin pumps, and whole organ pancreas and isolated islet cell transplantation. In addition, dietary manipulation, including the use of alpha-glucosidase inhibitors, has played a role in controlling glycaemia.
Similar articles
-
Oral antidiabetic agents: current role in type 2 diabetes mellitus.Drugs. 2005;65(3):385-411. doi: 10.2165/00003495-200565030-00005. Drugs. 2005. PMID: 15669880 Review.
-
Current management of diabetes mellitus and future directions in care.Postgrad Med J. 2015 Nov;91(1081):612-21. doi: 10.1136/postgradmedj-2014-133200. Epub 2015 Oct 9. Postgrad Med J. 2015. PMID: 26453594 Review.
-
[Intensified insulin therapy and insulin micro-pumps during pregnancy].Minerva Endocrinol. 1994 Jun;19(2):79-83. Minerva Endocrinol. 1994. PMID: 7968932 Review. Italian.
-
Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.Am J Med. 1996 Apr;100(4):412-7. doi: 10.1016/S0002-9343(97)89516-2. Am J Med. 1996. PMID: 8610727 Clinical Trial.
-
Current status and future of implantable insulin pumps for the treatment of diabetes.Expert Rev Med Devices. 2004 Nov;1(2):181-5. doi: 10.1586/17434440.1.2.181. Expert Rev Med Devices. 2004. PMID: 16293038 Review.
Cited by
-
Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation.Transplantation. 2008 May 27;85(10):1456-64. doi: 10.1097/TP.0b013e31816fc0ea. Transplantation. 2008. PMID: 18497687 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical